Download Pediatric Chemotherapy - Mid

Pediatric Chemotherapy
Gina Brandl, RN BSN, MSN-Cand
Nursing Instructor
MSTC - Pediatrics
1
Objectives
• The student will describe how chemotherapy
works on cells normal and cancerous cells
• The student will describe the common side
effects of chemotherapy
• The student will assist in developing a nursing
care plan appropriate for the pediatric
patient receiving chemotherapy
2
Chemotherapy
• Chemotherapy
– Specific drugs
• Kill normal and cancerous cells
• Given simultaneously
– Achieves greatest cellular destruction
• Alters DNA
– Administration
• Intrathecal (into spinal canal), oral or
intravenous
3
Protocols
• Type of cancer
• Cell type
• Location and spread
• Drug
• Dose
• Interval of treatment
Treatment for side effects
Necessary laboratory studies
(London et al., 2007)
4
Other Drugs Used
• Other drugs used in cancer treatment
– Colony-stimulating factor
• Erythropoietin (Epoetin)
• Filgrastim (Neupogen)
– Antimetics
• Ondansetron (Zofran)
– Nutritional supports
• Help to maintain nutritional support
– TPN & Lipids
5
Side Effects of Chemotherapy
• Occur when healthy cells are damaged
– Occurrence
• Immediately
• Week to ten days
• Months to years
– Permanent or temporary
– Includes: hair loss, mouth sores,
constipation, bone marrow suppression,
nausea and emesis, anorexia and weight loss
6
Side Effects of Chemotherapy
• Hair loss
• Mouth sores
• Pain
• Constipation
• Bone marrow
suppression
• Nausea and vomiting
• Anorexia and weight
loss
7
Nursing Care Plan
• Nursing diagnosis
– Risk for infection r/t immunosupression,
invasive procedures, malnutrition, or
pharmaceutical agents
• Goals, interventions with rationale and expected
outcomes
– Ineffective individual coping r/t situational
crisis
• Goals, interventions with rationale and expected
outcomes
8
References
London, M. L., Ladewig, P. W., Ball, J. W., & Bindler, R. C.
(2007). Maternal & child nursing care (2nd ed.). Upper
Saddle River, NJ: Prentice Hall.
Saint Joseph’s Hospital. (2006). Pediatric oncology – Education
& resource guide. Marshfield, WI; Ministry Health Care
Steinbrook, R. (2007). Erthropoietin, the FDA, and oncology.
The New England Journal of Medicine. 356(24), p. 248.
Retrieved December 16, 2007, from the website
http:proquest.umi.com.ezproxy.apollolibrary.com/pqdweb?did=
128822401901&sid=6&Fmt=3&clientid=13118&RQT=309&VNa
me=PQD
9